Back to Trials
NCT06518928RecruitingAccepts Healthy Volunteers

SprmPik AI Sperm Selection Study SiD, an Assistant for Sperm Selection During Intracytoplasmic Sperm Injection in Medically Assisted Reproduction: Effect on Fertilization, Blastocyst Formation, Early Pregnancy Loss, and Consistent Practice. A Prospective Pilot Study.

Ovation Fertility

Start Date

1/1/2024

Completion Date

10/1/2026

Summary

SprmPik AI Assisted Sperm Selection Study SiD, an assistant for sperm selection during intracytoplasmic sperm injection in medically assisted reproduction: effect on fertilization, blastocyst formation, early pregnancy loss, and consistent practice. A prospective pilot study.

Detailed Description

The purpose of this research is to evaluate the impact of sperm selection for ICSI using the investigational SiD software, on performance outcomes such as the rate of fertilization, blastocyst development, clinical pregnancy success, and other intermediate results, in a pilot study. SiD is a software designed to identify, evaluate, and assist in the sperm selection process within a semen sample, according to motility (for instance velocity, linearity, straightness) patterns and the shape of the sperm. SID uses a mathematical model. Its purpose is to assist clinical embryologists in selecting sperm to inject during ICSI. Currently, embryologists identify and select sperm based on the sperm motility and shape; not using any mathematical interphase assistant.

Eligibility Criteria

Age Range: No minimum to No maximum

Inclusion criteria for Male Partner (sperm source) * Informed consent signed by the patient before treatment. * IVF treatments with medical or embryology indication to perform ICSI. * Fresh or frozen ejaculated motile sperm. * Selection of sperm using a 7% or 10% PVP solution. * Presence of motile sperm at the time of sperm selection for ICSI. * Partner sperm Exclusion criteria for Male Partner (sperm source) * Sperm extracted by testicular biopsy. * That the recommendations for use of SiD have not been fully followed. * Inability to reliably trace sperm-oocyte-embryo throughout the process. * Patients with immotile sperm Inclusion criteria for Female Partner (egg source) * Informed consent signed by the patient before treatment. * IVF treatments with medical or embryology indication to perform ICSI. * Cycles with at least 4 mature oocytes (Metaphase II). * Fresh or frozen oocytes. Exclusion criteria for Female Partner (egg source) * Inability to reliably trace sperm-oocyte-embryo throughout the process. * Oocytes that are not in Metaphase II.

Interventions

OTHER

Artificial Intelligence assisted sperm selection

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Infertility

Locations

Ovation Fertility Las Vegas

Las Vegas, Nevada 89113

United States

Ovation Fertility - Austin

Austin, Texas 78731

United States